| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Eric Adler is Chief Medical Officer at LXEO. Eric Adler's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $226K at current prices.
Our model assigns Eric Adler a below-average insider score of 46/100, based on 5 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -6.4%.
The LXEO filings lean toward selling, a net 7,549 shares.
Eric Adler has 7 Form 4 filings on record from February 2024 to November 2025, all as Chief Medical Officer at Lexeo Therapeutics (LXEO), 2024–2025.
The 11 reported transactions were 6 open-market sales, 3 stock awards and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $51K.
The largest open-market sale was 3,382 shares of LXEO at an average $8.94 on October 17, 2025, about $30K. Twelve months later LXEO was down 72%.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 615 | $9.27 | $5,701.05 | -0.8% | -31.6% | - | |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 3,382 | $8.94 | $30,241.96 | -4.4% | -21.7% | -72.4% | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 608 | $4.67 | $2,838.14 | -0.9% | +92.7% | +0.2% | |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 585 | $2.77 | $1,622.79 | -0.9% | +47.8% | +57.1% | |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Medical Officer | Sell | 2,359 | $4.41 | $10,410.27 | -3.3% | -20.9% | +40.6% |